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Abstract 
This paper will focus on the effects of maternal substance use on the gestational 
development of neonates.  The research for this paper will be gathered through a 
systematic review of the literature, which will include both quantitative and qualitative 
peer-reviewed articles published within the last six years.  The articles will be gathered 
using databases including CINAHL and EBSCO.  The research will include many 
substances that can have an effect on gestational development including alcohol, 
cannabis, amphetamines and opioids.  The articles will not be limited to a specific 
maternal age range or ethnic or racial background, but rather all of the articles will 
include women who used substances at any point during their pregnancies.  The 
demographics of the women and their socioeconomic status will be taken into 
consideration when analyzing the outcomes of the fetuses.  For the purposes of this 
article, there will be a zero tolerance of substance use allowed during pregnancy and any 
use above zero would be considered abuse.  The research will look into the roles of the 
women, their existing families and the physicians.  The research will also explore the 
relationship between previous substance use and use during pregnancy.  Some current 
research supports that there is a definite risk in healthy development of a fetus when 
substance use occurs during pregnancy.  There are many outside factors, such as marital 
status, socioeconomic status and social class, that play a role in the resources available as 
well as the treatment provided to these women and fetuses.  The goal of this study is to 
spread awareness of the effects of substance use during pregnancy and to help not only 
health care providers, but also women become more educated in the area, and therefore 
make more knowledgeable choices.     
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Introduction 
 Fetal development is an extremely delicate process that has been experienced by 
families all over the world since the start of time.  For nine straight months, the female 
acts as the sole provider in sharing all of her body’s resources to fuel the fetus to grow 
into a healthy baby. There are many factors that contribute to the ongoing dispute on 
substance safety during pregnancy, and a major issue is physicians.  According to 
research, “approximately 1-3% of all children born in the U.S. are affected by alcohol.”  
(Truong, Reifsnider, Mayorga & Spitler, 2012).  Unfortunately, not all doctors agree that 
substance use must be completely stopped during all three trimesters of pregnancy, and 
believe that in moderation substance use, especially alcohol, is tolerable by the fetus.  
However, countless trials and research articles beg to differ and support the idea that the 
safest pregnancy is one that abstains from all substance use.  In addition to the support 
from physicians to use substances in moderation, there are currently more substances that 
are becoming legal in various countries, making substances more easily accessible to the 
general public.   
Background/Significance 
Substance abuse during pregnancy profoundly impacts the healthy development 
of the unborn child.  Despite known knowledge about the long-term effects that 
substances cause on gestation and neonates, there are providers and parents that refuse to 
believe all substances are harmful and advise mothers that limited substance use during 
pregnancy is safe.  A study found that even, “consumption of 1-2 drinks/week,” 
contributes to the risk of delivering a baby preterm. (Truong et al., 2012).  With the 
increase in substance availability and ongoing debate on their legal status, this issue is 
Running head: EFFECTS OF MATERNAL SUBSTANCE USE 
 
2  
going to become even more prevalent in generations to come. When mothers make the 
decision to continue or begin using substances during pregnancy, they put their fetus and 
neonate in grave danger.  According to Truong, when a mother drinks, she puts her child 
at risk for developing fetal alcohol syndrome, an irreversible condition that contributes to 
cognitive and behavioral delays for the duration of the child’s life.  In addition, when 
substances are used during gestation the fetus is at increased risk to be born prematurely, 
affecting the chance of survival, as well as being born with a low birth weight, affecting 
the overall growth and development. (Truong et al., 2012). 
Age is another factor to consider when looking into maternal substance use.  
According to a study, “the normative timing of pregnancy in the U.S. is for women ages 
20-34.” (Meschke, Holl & Messelt, 2012).  During this time frame, it is important to look 
at the whole picture of the mother’s life.  Demographics play a large role in a mother’s 
substance use during pregnancy.  It is more common for a woman who is unmarried and 
pregnant to experience depression-like symptoms and turn to substance use.  On top of 
that, it may be harder for women who are single or who do not have the financial means 
to reach out to a rehabilitation program to seek help.  It is important to look at the big 
picture and see in what ways maternal substance use can be decreased if not stopped.   
Aim of Study 
 The purpose of conducting this research was to look into the misconceptions of 
maternal substance use during pregnancy and see where the communication of the full 
effects is inadequate.  There are far too many infants born withdrawing from countless 
substances and not enough resources available for mothers.  Research has supported that 
women of varying ages who become pregnant continue to use and abuse substances 
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throughout their pregnancies.  It is clear that there is a significant lack of communication 
in terms of physicians and patients and the resources available to help them deliver a 
healthier baby.     
Methods 
A systematic review of the literature was the method used to look further into the 
effects of substance use during pregnancy on fetal development.  I have used the database 
CINAHL and EBSCO as my main sources of gathering articles to examine.  The criteria I 
am using when selecting my data is only peer-reviewed articles that have been published 
within the last 6 years (2010-2016).  My articles are all about women who are using 
substances while pregnant and look into the different demographics that played a role in 
their substance use.  The articles include articles published all over the world; I did not 
choose to narrow my search to a specific region.  I looked for articles that included both 
qualitative and quantitative methods of data collection.  My keywords were: maternal 
substance use or abuse, neonates, pregnancy and development.  I composed a flow map 
included in Appendix A where I specifically narrow down my research articles by 
process of elimination in choosing which articles best fit my topic of research.  There was 
no specific exclusion criteria, my articles all pertain to women because only females can 
become pregnant and then experience the ramifications of substance use and pregnancy. 
Some articles discussed how a woman’s relationship status played a role in whether or 
not they engaged in substance use while pregnant.  I did not look into a specific age range 
or race.  I left my research open to get a look at women of all ages I all different cultures. 
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Results 
 After reviewing the literature, many common themes arose about maternal 
substance use and the effects on gestational age and neonates.  Eight articles that fit the 
parameters of the research topic and each touched upon different aspects of maternal 
substance use during pregnancy were used as the basis of this systemic review of the 
literature.  The first study looked at urine samples of 690 Danish women in various age 
groups at their 12-week ultrasound visit and tested to see if any substances were being 
used.  The urine tests were spread out between 8 hospitals to assess different populations 
of people.  To the surprise of researchers, 3.6% of the women tested positive on their 
initial urine test, and then again on a repeated test.  Initially, the researchers were 
predicting that 1-3% of the pregnant women would test positive for substances in their 
urine, showing just how underestimated this issue is.  Further, of the group that tested 
positive for substance use, 88.4% tested positive for opiate use.  The study also brought 
to light a very important theme that just because a woman receiving prenatal care does 
not appear to be using substances, all women should be tested during their prenatal visits.  
Health care providers should not just assume women are abstaining from substances, 
because it is clear there are more women than predicted using. (Rausgaard, Ibsen, 
Jørgensen, Lamont & Ravn. 2014). 
 An additional study with a similar theme set out to look at the incidence of babies 
born with neonatal abstinence syndrome (NAS) as well as the number of babies born 
exposed to narcotic use in Ontario, Canada.  The study was conducted in 2010, and 
during that time the number of maternal narcotic users went from 8.4% to 17.2%, 
showing just how quickly the number of maternal substances users is rising.  Of the 482 
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live births looked at in this study, 61 of the babies were born to mothers who exposed 
them to substances during gestation.  In this study, many of the mothers who used during 
pregnancy were seen to use the substances in a binging pattern.  A common theme found 
through the study was how mothers who used narcotics during pregnancy were more 
likely to deliver a premature baby.  Premature delivery requires a longer hospital stay, 
adding more stress to the mother and her family.  Mothers who engaged in narcotic use 
were also more likely to use alcohol and other substances as well.  Babies who are born 
addicted to substances experience withdrawal symptoms and have a much harder 
beginning of life.  The babies often experience hyperirritability and have trouble 
consoling themselves.  As the drug use among individuals rises, health care providers are 
noticing a domino effect in the number of babies exposed to substances during gestation.  
More and more mothers are testing positive for drug use at prenatal visits, or if missed, 
more babies are born preterm experiencing NAS.  (Kelly et al., 2011). 
 Continuing on with the effects of substance use during gestation, the next study 
looked into one of the more serious side effects these neonates withstand: low birth 
weights.  The study was a systematic review of the literature that sought out whether or 
not there is a clear relationship between maternal binge drinking and preterm births as 
well as low birth weight infants born in the United States.  A common issue fetuses 
exposed to alcohol experience is FAS or fetal alcohol syndrome.  This is a serious 
lifelong developmental issue that the child will have to live with for the rest of their lives.  
Some mothers either do not believe this is caused by drinking during gestation, or they 
believe it is irreversible: both of those ideals being false.  Even if the child is born 
without FAS, it is likely that the infant will have serious cognitive and behavioral issues.  
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The research found that alcohol consumed at any point throughout the pregnancy showed 
effects to the fetus, especially preterm birth.  Even women who engaged in 1-2 drinks per 
week saw adverse effects to their infant.  The issue this study brought about is the lack of 
knowledge and communication in the causes and prevention of preterm and low birth 
weight infants, so the numbers continue to rise.  The study went on to look at different 
demographics and looked into women of various races, ethnicities and ages, and still the 
same results were found. (Truong, Reifsnider, Mayorga & Spitler, 2012).   
 A common misconception that researchers were curious about was the age range 
of mothers who were more likely to use substances during pregnancy.  It is commonly 
assumed that younger mothers would be the majority of mothers giving birth to children 
exposed to substances, but this next study went on to explain that age is but a number 
when it comes to substance use.  Maternal substance use during gestation was seen across 
the board in terms of maternal age.  The study went on to look at what predisposing 
factors could lead a mother to drink such as history of alcohol abuse, depression and 
being unmarried to name a few.  The study found that although teen pregnancies seem to 
have the most predisposing factors against them, there are more women, particularly 35 
years and up, who engage in substance use during pregnancy.  As discussed in the 
previous study, alcohol consumption during pregnancy can lead to serious effects on the 
fetus, commonly seen as FASD or fetal alcohol spectrum disorders, more seriously FAS.  
Not only will the child have serious developmental delays, the hospital bills and care for 
the child will be much more strenuous and expensive for the mother. (Meschke, Holl & 
Messelt, 2012).   
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 A different study looked into just what services are available for women who are 
seeking treatment for their substance use during their pregnancies and just how easily 
accessible the services are.  This study focused more on the demographics of women who 
were using substances during their pregnancies and the challenges these mothers faced 
when seeking help.  The case study included interviews not only with mothers, but also 
with child protection service workers.  Of the twenty-two women interviewed, only one 
used heroin exclusively, the others reported being polydrug users.  Also, of this group, 
the women shared that the majority of their pregnancies were not planned.  Unplanned 
pregnancies and substance use, in this study, seemed to go hand in hand.  Along with 
unplanned pregnancies, the research found that women who lived unstable lives, such as 
being victim to domestic abuse, also saw an increase in substance use during gestation.  
There was also a high risk of repeated pregnancies where substance use was an issue.  
The study found that a good portion of the women included in the study had either been 
exposed to child protective services as a child or had a previous child looked into by the 
system.  The relationship of women who have multiple pregnancies while using 
substances is a frightening realization, because clearly there is a gap in the system.  Child 
service agencies observe the maternal substance use through routine urine tests and 
checkups, but it is evident that this is not enough.  Many cases where child services are 
involved include multiple children born to the same mother repeatedly engaging in 
substance use.  Since most child service agencies only follow through with the mother 
until the infant is twelve months old, it is suggested that the watch period needs to be 
extended to prevent these repeat offenders.  (Tsantefski, Humphreys & Jackson. 2013). 
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 Another very common theme in the literature was looking at the comparison 
between withdrawal medications for maternal substance users and which medications 
were safest for the fetus.  The medications looked at were buprenorphine and methadone 
in place of opiate substances.  A retrospective audit completed on mothers seeking help 
for their substance use during gestation compared the end results and neonatal withdrawal 
periods of mothers who sought methadone or buprenorphine from a prescriber instead of 
continuing with higher risk drugs.  The study found that even with the switch to 
methadone or buprenorphine, just under half of the infants faced at least one complication 
after delivery.  The complications faced included infection, jaundice, small for gestational 
age, low birth weight, poor feedings and respiratory distress syndrome.  The other half of 
the infants still faced NAS, with two infants being stillborn.  The study found that even 
mothers who switch to methadone or buprenorphine are going to have infants that 
experience withdrawal periods on top of numerous complications, however methadone 
and buprenorphine can at least be given in controlled doses and monitored by a licensed 
prescriber.  The outcomes for these neonates are better if the mother seeks antenatal care 
and switches to a safer substance, but ultimately even these controlled substances are not 
safe for the fetus.  (Blandthorn, Forster & Love, 2010).  
 In a similar study, methadone and buprenorphine were again looked at in terms of 
their safety and effectiveness on fetal development and the presence of NAS, but the 
research was conducted as a literature review rather than a trial.  The article discussed 
how any prescriber of a substance to a pregnant woman should be conscious of the risk to 
benefit ratio.  Since methadone and buprenorphine both cross the placenta the fetus is at 
risk for adverse reactions to the drugs, however it is seen as a safer bet than allowing the 
Running head: EFFECTS OF MATERNAL SUBSTANCE USE 
 
9  
mother to continue using opiates.  This study went on to discuss which approach is safer 
for the fetus, seeing as methadone is an older more widely prescribed medication over 
buprenorphine.  After reviewing literature that compared non-stress tests and fetal heart 
rates of mothers using both drugs, the results were interesting.  The research found that 
more fetuses actually experienced a decrease in motor activity during gestation and had 
comparably lower heart and respiratory rates compared to those exposed to 
buprenorphine.  Further, the research found in some instances, not all, neonates 
experienced a shorter withdrawal period when exposed to buprenorphine versus 
methadone.  Further research has to be conducted to get a better representation of the 
effects of buprenorphine since methadone has been prescribed for a much longer time.  
The research stresses that although methadone and buprenorphine suppress the urge to 
use opiates, they are not a cure for addiction and still have adverse affects on the fetus.  
(Jones, Finnegan & Kaltenbach, 2012). 
In a final study, literature regarding maternal and neonatal outcomes using 
specifically buprenorphine was researched.   The information considered for the study 
included both published articles and clinical trials conducted.  The article looked into 
buprenorphine alone because other research has suggested a shorter period of NAS when 
compared to methadone or opiates.  This research continued to support the idea that 
buprenorphine causes a shorter period of NAS in comparison to methadone, and less 
motor functions were suppressed.  Looking further into the long-term effects a neonate 
might face, this research looked into the transference of buprenorphine into breast milk.  
The research found that even though the buprenorphine is able to pass to the breast milk, 
it passes in such low concentrations leading researchers to support the idea that, thus far, 
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there are no side effects noted in mothers who breast feed while continuing to use 
buprenorphine. (Jones et al., 2012) 
Discussion 
 Countless ideas and themes were relevant across the board in terms of the effects 
of maternal substance use on gestation and further neonatal development.  Common 
demographic information about the women who were more likely to use substances 
during pregnancy included but was not limited to martial status, employment status, 
upbringing, and in some cases age.  Women who were single and tended to lack a support 
system were seen to be under more stress and turned to substance use.  In addition, 
women who did not have jobs and were under financial stress were less likely to seek 
antenatal care and their substance use went unnoticed until birth.  These factors all 
contribute to the number of women using substances and consequently the number of 
fetuses and neonates affected. 
 Research on the effects of substance use on fetal development in all cases studied 
concluded there are adverse effects any time substances are used during gestation.  Even 
in moderation, fetal development runs the risk of being altered.  Substances not only 
effect how the fetus grows and develops, but it affects the safety of the mother and the 
pregnancy.  Many illicit drugs lead to hypertension, which is a huge component in 
placental issues and early delivery.  As discussed in the results, preterm fetuses are faced 
with many growth and development risks due to the lack of time in the mother.    
 Even mothers who sought treatment for their substance use were faced with the 
reality that even though some of the substances that can be prescribed, such as methadone 
and buprenorphine, do not come without risks as well.  Many neonates still experienced 
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withdrawal and growth issues, although much less and of shorter duration than those 
exposed to opiates.  The safest way to ensure the least amount of harm to the fetus is to 
abstain from substance use throughout the entire pregnancy.  
Conclusion/Recommendation 
 The information examined in this study is important for health care providers and 
the public to understand because research is continuing to see an increase in the number 
of maternal substance users, leading to various adverse effects on gestational 
development.  The topic is one that has been overlooked for many years and still carries 
some information that is contradicted by physicians.  Research goes to support that even 
drinking alcohol in moderation leads to serious developmental and behavioral delays.  On 
top of that, use of substances during pregnancies lead to a plethora of issues for the 
neonate to face.  Numerous studies looked into the use of methadone and buprenorphine 
as treatment options for mothers, and found not only do these substances not cure opioid 
addiction, but also they are not completely safe for the fetus either.  More awareness 
needs to be brought upon the issue of substance use during pregnancy to reduce the 
number of infants bore experiencing withdrawal.   
 From a nursing and public health perspective, further research should be done to 
determine a safer way for mothers and infants to withdraw from substances.  Currently, 
the method of controlled withdrawal during pregnancy is not completely safe for the 
fetus, and the infant still experiences withdrawal symptoms.  Also, there needs to be clear 
communication between health care providers and women on the parameters of safe 
substance use during pregnancy.  Despite countless studies, some health care providers 
still support the idea that limited substance use in pregnancy is safe.  If communication is 
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not clear, there will not be a drastic decrease in substance use during pregnancy.   Further 
recommendations should also include looking into the care women receive before and 
after the pregnancy.  Research suggests checkups through child services last for about 
twelve months in these cases, and it is not uncommon to see the same women use 
substances again during future pregnancies.  More investigation needs to be done for all 
women seeking prenatal care, and more extensive testing needs to be done so the fetus 
can receive treatment as soon as substance use is suspected.  Health insurance policies 
and prenatal clinics also need to look into their requirements for visits so that women 
with less financial support can seek treatment during pregnancy. 
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Appendix B 
Flow Map: 
Keywords: maternal substance use or abuse pregnancy  
 
Initial search 1015 articles 
 
 
Criteria: Peer Reviewed 
 
793 articles 
 
 
Criteria: Published between 2010 – 2016 
 
224 Articles 
 
 
42 Abstracts meet study criteria 
 
 
42 read and 20 articles were relative and useful  
8 have been thoroughly reviewed at this point 
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Appendix C 
 
Citation Author(s)/ 
Year 
Design  Target 
Populatio
n, Sample 
Size, 
Location 
Type Intervention  Outcomes/Aims Results  Limitations Maternal Substance Use 
and Pregnancy and/or 
Neonatal Development 
 Nursing Implications/Gaps 
Blandthorn, J., Forster, D. A., & 
Love, V. (2011). Neonatal and 
maternal outcomes following 
maternal use of buprenorphine or 
methadone during pregnancy: 
Findings of a retrospective audit. 
Women and Birth, 24(1), 32-39. 
doi:10.1016/j.wombi.2010.07.001 
 
Quantitative 96 
Women, 
average 
age – 29 
years old, 
Royal 
Women’s 
Hospital 
 
Data collected 
included: 
demographic 
characteristics; 
gestation at 
booking; number 
of antenatal visits; 
labour and birth 
outcomes; 
recorded drug use; 
neonatal 
outcomes; and 
infant withdrawal 
outcomes. 
The outcome was 
that there is 
definitely a rise in 
poly-substance use 
among pregnant 
women. The aim 
is to better educate 
and control this 
situation.  
Further 
prospective 
research is 
required to explore 
whether factors 
such as specific 
substances are 
more likely to be 
associated with 
infant withdrawal. 
 
Study was 
conducted at one 
hospital making 
the data slightly 
biased. A wider 
range of data 
would have 
helped. 
Neonatal outcomes are 
better for infants of 
substance using mothers 
if the women have been 
engaged in antenatal 
care 
Educating maternity care 
providers as to the risks of 
substance use in pregnancy is 
important. Eighteen percent of the 
women in this audit were 
prescribed pharmacotherapy and 
attended low risk pregnancy 
clinics. Given the prevalence of 
poly-drug use and the likely 
under-reporting of this in women 
prescribed pharmacotherapy, it is 
crucial for staff to ask women 
directly about substance use. 
Jones, H. E., Finnegan, L. P., & 
Kaltenbach, K. (2012). Methadone 
and burprenorphine for the 
management of opioid dependence 
in pregnancy.Drugs, 72(6), 747-
757. 
doi:10.2165/11632820-
000000000-00000 
 
Qualitative  Women 
engaging 
in 
substance 
use, 
primarily 
opioids 
Findings are 
included from 
reviewing 
comparative 
studies involving 
methadone and 
buprenorphine use 
in replacement of 
opioids during 
gestation. 
The outcomes and 
aim was to look at 
the difference in 
the duration of 
withdrawal 
periods for 
neonates exposed 
to methadone or 
buprenorphine 
versus opioids.  
The results 
supported the idea 
that methadone 
and buprenorphine 
are safer for a 
neonate.  
The study did not 
include a clinical 
trial; rather it 
looked at 
published 
literature. 
Another clinical 
trial to compare 
would be helpful 
 
The research showed 
that neonates suffer 
much less withdrawal 
periods when on 
buprenorphine and 
methadone in 
replacement of opioids. 
The duration of NAS 
was much shorter, and 
the neonates suffered 
less motor function 
abnormalities.  
The implications from this study 
would be to continue to push and 
educate women who are using 
substances such as opioids during 
pregnancy seek help and gain 
treatment. The treatment with 
these substances provides a much 
safer outcome for the fetus.  
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Jones, H. E., Heil, S. H., Baewert, 
A., Arria, A. M., Kaltenbach, K., 
Martin, P. R., …Fischer, G. 
(2012). Buprenorphine treatment 
of opioid-dependent pregnant 
women: a comprehensive review. 
Addiction, 107, 5-27. 
doi:10.1111/j.13600443.2012.0403
5.x 
 
Qualitative  44 non-
randomize
d studies 
involving 
the use of 
buprenorp
hine 
The paper reviews 
published 
literature 
involving clinical 
trials looking at 
the outcomes of 
buprenorphine use 
The outcome and 
aim was to 
compare outcomes 
of maternal 
treatment using 
buprenorphine 
The results 
indicate that the 
use of 
buprenorphine is 
in fact safer for the 
mother and the 
fetus and that 
buprenorphine is 
safer than 
methadone.  
The study was 
limited in the 
aspect that there 
was not another 
method 
compared in 
which the mother 
and fetus were 
free of adverse 
effects 
The research supported 
that buprenorphine is 
going to be a better 
form of withdrawal 
medication for mothers 
using opioids during 
pregnancy because 
research support sit has 
less side effects than 
methadone, the more 
commonly accepted 
form of drug therapy.  
The implications would be to 
continue to look into this method 
of drug therapy and get the word 
out to increase prescriber 
awareness and make this method 
more widely used since it is 
clinically proven to be more 
effective and less harmful than 
popular therapies. 
Kelly, L., Dooley, J., Cromarty, 
H., Minty, B., Morgan, A., 
Madden, S., Hopman, W. (2011). 
Narcotic-exposed neonates in a 
first nations population in 
northwestern 
Ontario. Canadian Family 
Physican, 57, 441-447. 
www.cfp.ca/content/57/11/e441.f
ull.pdf+html 
 
Retrospecti
ve Chart 
Review 
Mothers 
and 
neonates 
for 482 
live births 
during 
January 
2009 to 
June 2010 
in 
Ontario, 
Canada.  
The research 
includes data 
collected through 
summaries of 
patients’ charts 
and prenatal 
clinics.  
The outcome and 
aim of the study is 
the document the 
incidence of 
neonatal 
abstinence 
syndrome and the 
rising rates of 
narcotic use 
during pregnancy.  
The study found 
that the incidence 
of narcotic use 
during pregnancy 
has greatly 
increased form 
8.4% to 17.2% 
during the time of 
the study alone.  
The study also 
looked at the end 
effects of 
substance use 
during gestation 
and the number of 
infants born with 
NAS.  
The population 
of women 
limited the study; 
only 482 
pregnancies were 
looked into in 
one population of 
people. The 
study was also 
limited in the fact 
that data was 
collected on a 
basis of trust and 
by word of 
mouth. It is hard 
to make 
conclusions that 
stick when 
people can lie 
about their 
substance use 
and symptoms.  
The study supported 
that there is a serious 
jump in the number of 
women engaging in 
substance use while 
pregnant and that there 
need to be clear 
interventions to 
decrease this 
occurrence. The study 
also came to the 
conclusion that more 
needs to be done within 
communities to help this 
population. 
 
The implications would be to look 
further into this area and to 
continue to work on community-
based initiatives to facilitate these 
patients in receiving care.  Also, 
there should be further studies 
into was healthcare providers can 
assist in slowing down the 
progression of maternal substance 
use during pregnancy. 
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Meschke, L. L., Holl, J., Messelt, 
S. (2012). Older not wiser: risk of 
prenatal alcohol use by maternal 
age. Matern Child Health J, 17, 
147-155. doi:10.1007/s10995-
0120953-7 
 
Quantitative 9,004 
women 
from 
north 
central 
U.S who 
were 
pregnant 
from all 
ages who 
engaged 
in none to 
frequent 
alcohol 
use during 
gestation. 
Descriptive and 
logistic regression 
analyses were 
completed on 
surveys completed 
at prenatal visits 
The descriptive 
analyses were 
done to examine 
age group 
differences in the 
occurrence of 
prenatal alcohol 
use and identify 
predisposing risk 
factors if any 
The study 
concluded that 
women of all ages 
engaged in 
drinking, there 
was no specific 
age range that had 
more or less 
occurrences. The 
study did find 
however, that 
there is more 
weight placed on 
socioeconomic 
factors than age 
when looking at 
risk factors for 
drinking alcohol 
while pregnant.  
The limitations 
this study faces 
are the fact that it 
is limited in 
number of 
participants and 
the scope of the 
survey. The 
study suggested a 
qualitative study 
may have 
revealed more 
information 
regarding 
predisposing risk 
factors. The 
survey was also 
somewhat brief, 
based on nature 
of the study the 
brevity worked 
to benefit the 
number of 
participants.  
The study supports the 
idea that substance use 
is evident among all 
pregnant women of all 
ages. The study showed 
that alcohol use is in 
fact high during 
pregnancy and the most 
accurate was to assume 
if a women will engage 
in prenatal alcohol use 
is by predisposing risk 
facts over age.  
Nursing implications would 
include looking into the 
predisposing factors and clearly 
passing along education to women 
in birthing years about the 
important to abstain from alcohol 
during their pregnancy. The study 
would also benefit, as stated, from 
further research in a different 
method. Further more extensive 
research would benefit the data 
found.  
Rausgaard, N. L., Ibsen, I. O., 
Jørgensen, J. S., Lamont, R. F., & 
Ravn, P. (2014). Prevalence of 
substance abuse in pregnancy 
among Danish women. Acta 
Obstetricia Et Gynecologica 
Scandinavica Acta Obstet Gynecol 
Scand, 94(2), 215-219. 
doi:10.1111/aogs.12528 
 
 
Quantitative 
690 
pregnant 
women in 
Denmark 
Urinary screening 
for substance 
abuse took place at 
haphazardly 
chosen dates 
between January 
and May 2013, at 
the time of the 12-
week ultrasound 
scan, voluntarily 
and anonymously, 
in eight hospital 
antenatal clinics in 
the 
Region of 
Southern Denmark 
 
The outcome was 
that even though 
Denmark provides 
free health care 
there is a lack in 
report of women 
who use 
substances while 
pregnant. This 
leads researchers 
to believe there 
needs to be more 
screenings done at 
prenatal visits.  
This study, which 
we look upon as a 
pilot study, found 
an overall 
prevalence of 
substance abuse 
among pregnant 
women of 3.6% 
and that the age of 
pregnant women 
with confirmed 
positive samples 
was not 
significantly 
different from the 
age of the entire 
cohort 
 
Limitations 
included that the 
women were to 
remain 
anonymous so it 
was difficult for 
researchers to get 
the most 
information 
possible.  
Of 690 pregnant women 
who attended for 
ultrasound scan, 608 
(88.1%) provided a 
urine sample. A total of 
42 urine samples were 
positive on AccuSign 
(33 for opiates; four for 
cannabis; two for 
benzodiazepines; two 
for amphetamine; and 
one for 
methamphetamine) 
No one tested positive 
for more than one 
substance. Of screened 
samples positive for 
opiates and cannabis, 19 
of 33 were subsequently 
diagnosed as positive 
for opiates and three of 
four for cannabis. 
Accordingly, we would encourage 
an increased focus on substance 
abuse particularly among 
pregnant women without apparent 
indicators of abuse. A recent 
review from our group 
demonstrated that no biological 
sample has the ability to identify 
all substance users, and each 
sample has different advantages 
and disadvantages. 
Accordingly, we concluded that 
continuous maternal self-reporting 
of abuse and repeated urine 
testing during pregnancy provides 
the most accurate record of 
substance abuse 
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Truong, K. D., Reifsnider, O. S., 
Mayorga, M. E., Spitler, H. (2012). 
Estimated number of preterm 
births and low birth weight 
children born in the United States 
due to maternal binge drinking. 
Matern Child Health J, 17, 677-
688. doi:10.1007/s10995-012-
1048-1 
 
Qualitative  American 
sociodem
ographic 
groups in 
2008 
A stimulation 
model was created 
to estimate the 
number of preterm 
births and low 
birth weight 
babies were born 
in the united states 
in 2008 
The outcome of 
the study was to 
estimate the 
burden of maternal 
binge drinking and 
the effect it had on 
delivery timing 
and neonatal birth 
weight. 
The results of the 
study were clear 
and supportive of 
the aim. There was 
a clear relationship 
between alcohol 
consumption and 
low birth weight 
and preterm 
delivery. The 
drinking did not 
have to be in binge 
fashion to support 
the data, the study 
found that even 
moderate drinking 
increased the 
chances of 
experiencing these 
difficulties.  
The limitation of 
this study was 
the fact that it 
was a stimulation 
model. Since 
binge drinking 
during pregnancy 
is very 
underreported it 
is hard to 
stimulate an 
accurate 
representation of 
the facts.  
The study supports the 
ideas that substance use 
during pregnancy has 
grave effects on the 
fetus. There was a clear 
relationship between 
alcohol consumption 
and birth issues, the 
major one being growth 
and development 
impairments.  
This stimulation study shows that 
there needs to be more concise 
research conducted on this topic. 
More reports need to be taken 
base on maternal substance use so 
that research can be more 
accurate. If research is more 
accurate there will be more 
validity and health care providers 
may take this topic more 
seriously.  
Tsantefski, M., & Humphreys, C., 
& Jackson, A. (2013). Infant risk 
and safety in the context of 
maternal substance use. Australia: 
Elsevier. 
 
Qualitative Twenty 
women in 
Australia 
accessing 
a 
specialist 
alcohol 
and other 
drug 
obstetric 
service 
 
Data sources 
included 
structured 
interviews with 
counselors and 
child protection 
workers and semi-
structured 
interviews with 
mothers 
 
Despite extensive 
activity by the 
Women's ADS in 
the perinatal 
period, 
engagement with 
services tended to 
be superficial and 
not well sustained: 
Women were 
reluctant to keep 
appointments 
made on their 
behalf and service 
providers failed to 
provide assertive 
outreach. Support 
to women with 
neonates at 
imminent risk of 
removal was 
largely con- fined 
to residential 
parenting 
assessment and 
skill development 
The present study 
demonstrates 
accurate 
assessment of at-
risk substance-
exposed infants by 
a specialist AOD 
obstetric provider 
and supports 
research 
identifying a sub-
group of infants at 
increased risk of 
separation from 
mothers. The 
longitudinal 
method illustrates 
that prac- tice is 
hamstrung by 
reliance on 
statutory services 
to monitor and 
inter- vene and 
that the current 
response does not 
lead to resolution 
Limitations 
would include 
the sample size, 
since only twenty 
women were 
looked at it is a 
small sample size 
to directly relate 
to the whole 
population 
The perinatal period 
was a time of optimism 
and concerted effort by 
mothers and service 
providers. At this time, 
women were likely to 
share the professional 
perception of risk and to 
address risk factors 
which could jeopardize 
care of the infant: drug 
use and domestic 
violence. While some 
disputed the need for 
mandated intervention, 
women involved with 
CP theoretically 
acknowledged the 
important role the 
service plays in 
protecting women and 
infants, generally 
accepted the presence of 
significant family 
problems and 
understood why 
If we are to restore the client's 
place in human service 
intervention, and uphold pa- 
rental rights to care for infants and 
the rights of infants to remain 
safely with parents, scarce 
resources need to be targeted to 
the most vulnerable mother/infant 
dyads, men need to be engaged as 
fathers and a relation- ship with a 
trusted professional needs to be 
established to ensure effective 
child welfare practice. 
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services, which 
provided minimal 
long-term support. 
 
of the issues that 
bring infants to the 
attention of child 
protection. 
 
notifications were made. 
Most women reduced or 
ceased drug use, and, as 
directed by CP, five 
women agreed to 
separate from, or not to 
return to, relationships 
with violent men. 
 
